Group B Streptococcus (GBS) is not sexually transmitted. It is a bacterium commonly found in the gastrointestinal, urinary, or genital tracts of healthy adults, including pregnant people. Transmission occurs through direct contact with bodily fluids during childbirth, not through sexual activity.
GBS colonization is widespread-about 25% of pregnant women carry it in their rectum or vagina at term. The bacteria do not cause symptoms in carriers, but they can pass to newborns during labor and delivery. This vertical transmission is the primary route of infant exposure.
The Centers for Disease Control and Prevention (CDC) states that GBS is not spread through casual contact, kissing, or sexual intercourse. Instead, it's acquired through close proximity to colonized areas, especially during vaginal birth. A woman may carry GBS at different times during pregnancy, making screening essential near delivery.
During labor, GBS can move from the mother's lower genital tract into the baby's mouth, nose, or eyes. If the baby swallows or inhales fluid containing the bacteria, infection can develop. The risk increases when the amniotic sac ruptures early or labor lasts longer than 18 hours.
Transmission is not guaranteed. Only about 1 in 200 babies born to colonized mothers develops early-onset GBS disease. However, without treatment, the consequences can be severe-sepsis, pneumonia, or meningitis. These conditions occur within the first week of life, most often within the first 24 hours.
A 2021 study published in *The Lancet Infectious Diseases* found that intrapartum antibiotic prophylaxis reduced early-onset GBS disease by 80%. This intervention is standard practice in the U.S., Canada, and many European countries.
Carriage rates vary by population. In the U.S., CDC data shows that approximately 25% of pregnant women test positive for GBS at 35-37 weeks gestation. Rates are slightly higher among Black and Hispanic populations compared to White women, though the reasons remain under investigation.
GBS is not linked to poor hygiene, immune deficiency, or lifestyle factors. It's a normal flora component in many people. The presence of GBS in a pregnant person doesn't indicate a health problem-it's simply a carrier state. The concern arises only when the baby is exposed during delivery.
One non-obvious fact: GBS carriage can change between pregnancies. A woman who tests negative in one pregnancy may test positive in a subsequent one. This variability underscores the need for screening in each pregnancy, not just once.
Many assume GBS is a sexually transmitted infection (STI) because it resides in the genital tract. This confusion stems from the location, not the mode of transmission. Unlike chlamydia or gonorrhea, GBS does not require sexual contact to spread.
Another misconception is that GBS causes long-term illness in adults. There is no evidence linking GBS colonization to chronic infections in otherwise healthy individuals. Adults with GBS may develop bloodstream infections or urinary tract infections, but these are rare and typically affect those with weakened immunity or underlying conditions.
GBS is not spread through breastfeeding, sharing utensils, or swimming in pools. The bacteria cannot survive long outside the human body. It requires warm, moist environments like mucosal surfaces to persist.
All pregnant people in the U.S. are routinely screened for GBS between 35 and 37 weeks of gestation. A swab is taken from the lower vagina and rectum. Results are reported as positive or negative.
If a woman tests positive, she receives intravenous penicillin during labor. This reduces the risk of passing GBS to the baby by up to 80%. The dose is given every four hours until delivery. For those allergic to penicillin, alternatives like cefazolin or clindamycin are used, though resistance patterns vary.
Here's a fully worked example: A 32-year-old woman at 36 weeks gestation undergoes GBS screening. Swabs from her vagina and rectum return positive. She goes into labor at 39 weeks. IV penicillin is administered at 5:00 PM, then every four hours. Her baby is delivered at 9:30 PM. The newborn is monitored for signs of infection. No symptoms appear. At 24 hours, the baby is healthy and discharged home. This outcome reflects the effectiveness of current guidelines.
| Factor | GBS Carrier Status | Non-Carrier Status |
|---|---|---|
| Prevalence in pregnant women | ~25% | ~75% |
| Transmission via sex | No | No |
| Transmission during birth | Possible (without treatment) | None |
| Antibiotic treatment during labor | Yes (penicillin) | No |
I've seen this process firsthand while working in a hospital maternity unit. A woman tested positive at 36 weeks. She was anxious, thinking she'd "caught" something dangerous. After explaining that GBS is not an STI and that treatment prevents harm, her anxiety eased. Her baby was born healthy, with no complications.
Testing for GBS is recommended for all pregnant people, regardless of symptoms. It's not based on past history or sexual behavior. Even if a woman had a negative result in a previous pregnancy, she must be retested in each pregnancy.
If a woman goes into labor before being tested, she may still receive antibiotics if she has certain risk factors: preterm delivery (<37 weeks), prolonged rupture of membranes (>18 hours), or fever during labor. These are red flags that increase the chance of GBS transmission.
Understanding that GBS is not sexually transmitted clarifies misconceptions and reduces stigma. It's a normal microbiome resident, not a sign of poor health or risky behavior. With proper screening and timely antibiotic administration, the risk to newborns is minimal.
Final clarification: GBS is not sexually transmitted. It is a common bacterium carried in the gut or genital tract. Transmission to infants happens during birth, not through sex. Routine prenatal screening and antibiotic treatment prevent serious illness in newborns.